THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM

被引：0
|
作者：
Choi, Bum Soon [1 ]
Choi, Sun Ryoung [1 ]
Park, Hoon Suk [1 ]
Hong, Yu Ah [1 ]
Chung, Byung Ha [1 ]
Kim, Young Soo [1 ]
Yang, Chul Woo [1 ]
Kim, Yong-Soo [1 ]
Park, Cheol Whee [1 ]
机构：
[1] Catholic Univ Korea, Div Nephrol, Dept Internal Med, Coll Med, Seoul, South Korea
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：442 / 442
页数：1
相关论文
共 50 条
  • [41] Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism
    Sterrett, J. R.
    Strom, J.
    Stummvoll, H-K
    Bahner, U.
    Disney, A.
    Soroka, S. D.
    Corpier, C.
    Arruda, J. A.
    Schwanauer, L. E.
    Klassen, P. S.
    Olson, K. A.
    Block, G. A.
    CLINICAL NEPHROLOGY, 2007, 68 (01) : 10 - 17
  • [42] Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism
    Ni, Zhaohui
    Liang, Xinling
    Wu, Chia-Chao
    Jin, Kyubok
    Kim, Yong-Lim
    Lu, Kuo-Cheng
    Chan, Tak Mao
    Fukagawa, Masafumi
    Kinoshita, Jun
    Nagai, Chisato
    Kojima, Masahiro
    Yu, Xueqing
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (11): : 2294 - 2306
  • [43] Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients
    Regidor, M. J. Aladren
    CLINICAL NEPHROLOGY, 2009, 71 (02) : 297 - 213
  • [44] Decreases in Parathyroid Gland Volume after Cinacalcet Treatment in Hemodialysis Patients with Secondary Hyperparathyroidism
    Ichii, Mitsuru
    Ishimura, Eiji
    Okuno, Senji
    Chou, Hidenori
    Kato, Yoko
    Tsuboniwa, Naoki
    Nagasue, Kyoko
    Maekawa, Kiyoshi
    Yamakawa, Tomoyuki
    Inaba, Masaaki
    Nishizawa, Yoshiki
    NEPHRON CLINICAL PRACTICE, 2010, 115 (03): : C195 - C202
  • [45] Cinacalcet use and risk of gastrointestinal bleeding in secondary hyperparathyroidism patients receiving maintenance hemodialysis
    Lin, Tzu-Chieh
    Guo, Haifeng
    Dluzniewski, Paul
    Peng, Yi
    Gilbertson, Dave
    Bradbury, Brian
    Nieman, Kimberly
    Sprafka, Michael
    Liu, Jiannong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 573 - 574
  • [46] 12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers
    Jean, G.
    Chazot, C.
    Charra, B.
    CLINICAL NEPHROLOGY, 2007, 68 (01) : 63 - 64
  • [47] Cost-Effectiveness of Cinacalcet Hydrochloride for Hemodialysis Patients With Severe Secondary Hyperparathyroidism in Japan
    Komaba, Hirotaka
    Moriwaki, Kensuke
    Goto, Shunsuke
    Yamada, Shunsuke
    Taniguchi, Masatomo
    Kakuta, Takatoshi
    Kamae, Isao
    Fukagawa, Masafumi
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (02) : 262 - 271
  • [48] Cinacalcet HCL for Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients: A Single Centre Experience
    Qaisar, Mansoor Abbas
    Nadeem, Muhammad
    Chattah, Fateh Sher
    Roop, Zarmina
    Hashir, Muhammad Mujtaba
    Iqbal, Bushra
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (04): : 995 - 997
  • [49] Cinacalcet treatment significantly deceases parathyroid gland volume in hemodialysis patients with secondary hyperparathyroidism
    Ishimura, Eiji
    Ichii, Mitsuru
    Okuno, Senji
    Inaba, Masaaki
    Nishizawa, Yoshiki
    ENDOCRINE JOURNAL, 2010, 57 : S491 - S491
  • [50] EFFECT OF SWITCHING FROM CINACALCET TO ETELCALCETIDE ON SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH HEMODIALYSIS; ESCORT TRIAL
    Kurokawa, Yuka
    Kaida, Yusuke
    Yano, Junko
    Takamiya, Yoshimi
    Otome, Takaomi
    Sugiyama, Miki
    Kojima, Aki
    Kumabe, Yuri
    Ito, Sakuya
    Kodama, Goh
    Nakamura, Nao
    Moriyama, Tomofumi
    Minami, Aki
    Nagata, Akiko
    Nakayama, Yosuke
    Shibata, Ryo
    Hazama, Takuma
    Fukami, Kei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 243 - 243
12345